» Articles » PMID: 37089425

Mouse Models of Preeclampsia with Preexisting Comorbidities

Overview
Journal Front Physiol
Date 2023 Apr 24
PMID 37089425
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia is a pregnancy-specific condition and a leading cause of maternal and fetal morbidity and mortality. It is thought to occur due to abnormal placental development or dysfunction, because the only known cure is delivery of the placenta. Several clinical risk factors are associated with an increased incidence of preeclampsia including chronic hypertension, diabetes, autoimmune conditions, kidney disease, and obesity. How these comorbidities intersect with preeclamptic etiology, however, is not well understood. This may be due to the limited number of animal models as well as the paucity of studies investigating the impact of these comorbidities. This review examines the current mouse models of chronic hypertension, pregestational diabetes, and obesity that subsequently develop preeclampsia-like symptoms and discusses how closely these models recapitulate the human condition. Finally, we propose an avenue to expand the development of mouse models of preeclampsia superimposed on chronic comorbidities to provide a strong foundation needed for preclinical testing.

Citing Articles

Streamlined Analysis of Maternal Plasma Indicates Small Extracellular Vesicles are Significantly Elevated in Early-Onset Preeclampsia.

Bowman-Gibson S, Chandiramani C, Stone M, Waker C, Rackett T, Maxwell R Reprod Sci. 2024; 31(9):2771-2782.

PMID: 38777947 PMC: 11393201. DOI: 10.1007/s43032-024-01591-y.


Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum.

Collins H, Alexander B, Care A, Davenport M, Davidge S, Eghbali M Am J Physiol Heart Circ Physiol. 2024; 327(1):H191-H220.

PMID: 38758127 PMC: 11380979. DOI: 10.1152/ajpheart.00055.2024.


Involvement of metalloproteinase and nitric oxide synthase/nitric oxide mechanisms in early decidual angiogenesis-vascularization of normal and experimental pathological mouse placenta related to maternal alcohol exposure.

Gualdoni G, Barril C, Jacobo P, Pacheco Rodriguez L, Cebral E Front Cell Dev Biol. 2023; 11:1207671.

PMID: 37670932 PMC: 10476144. DOI: 10.3389/fcell.2023.1207671.

References
1.
Echeverria C, Eltit F, Santibanez J, Gatica S, Cabello-Verrugio C, Simon F . Endothelial dysfunction in pregnancy metabolic disorders. Biochim Biophys Acta Mol Basis Dis. 2019; 1866(2):165414. DOI: 10.1016/j.bbadis.2019.02.009. View

2.
Gutaj P, Zawiejska A, Mantaj U, Wender-Ozegowska E . Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetol. 2017; 54(12):1115-1121. PMC: 5680366. DOI: 10.1007/s00592-017-1053-3. View

3.
Garovic V, Dechend R, Easterling T, Karumanchi S, McMurtry Baird S, Magee L . Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2021; 79(2):e21-e41. PMC: 9031058. DOI: 10.1161/HYP.0000000000000208. View

4.
Endres M, Laufs U, Liao J, Moskowitz M . Targeting eNOS for stroke protection. Trends Neurosci. 2004; 27(5):283-9. DOI: 10.1016/j.tins.2004.03.009. View

5.
Falcao S, Stoyanova E, Cloutier G, Maurice R, Gutkowska J, Lavoie J . Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension. 2009; 54(6):1401-7. DOI: 10.1161/HYPERTENSIONAHA.109.137356. View